AU4797779A - Substituted aminoalkanoic acids - Google Patents

Substituted aminoalkanoic acids

Info

Publication number
AU4797779A
AU4797779A AU47977/79A AU4797779A AU4797779A AU 4797779 A AU4797779 A AU 4797779A AU 47977/79 A AU47977/79 A AU 47977/79A AU 4797779 A AU4797779 A AU 4797779A AU 4797779 A AU4797779 A AU 4797779A
Authority
AU
Australia
Prior art keywords
signifies
liver
bile
stomach
exert
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU47977/79A
Other versions
AU525311B2 (en
Inventor
Dr. Krastinat
Dr. Riedel
Dr. Wolf
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda GmbH
Original Assignee
Byk Gulden Lomberg Chemische Fabrik GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Byk Gulden Lomberg Chemische Fabrik GmbH filed Critical Byk Gulden Lomberg Chemische Fabrik GmbH
Publication of AU4797779A publication Critical patent/AU4797779A/en
Application granted granted Critical
Publication of AU525311B2 publication Critical patent/AU525311B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/45—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
    • C07C233/46—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N37/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids
    • A01N37/12—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids containing the group, wherein Cn means a carbon skeleton not containing a ring; Thio analogues thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Biochemistry (AREA)
  • Dentistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Agronomy & Crop Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Saccharide Compounds (AREA)

Abstract

Acyl (bicyclic aryl) - aminoalkanoic acids of the general formula I <IMAGE> in which R<1> signifies an aliphatic or alicyclic hydrocarbon radical or an optionally substituted phenyl group, A signifies an optionally substituted and/or hydrogenated bicyclic aryl radical and n signifies 3, 4 or 5, as well as their salts of inorganic or organic bases exert in warm-blooded animals a protective action on the stomach and an increase in the pancreatic secretion, and in addition they exert an action on the liver and bile. Furthermore, they bring about an inhibition of the formation of glucose from lactate and pyruvate in the liver. They are suitable for the treatment and prophylaxis of diseases which a@ attributed to disorders of the stomach or intestine or to reduced performances of the pancreas, bile and/or liver, or the treatment of diabetes. Processes for the production of the compounds and suitable pharmaceutical products are given.
AU47977/79A 1978-06-14 1979-06-12 Substituted aminoalkanoic acids Expired - Fee Related AU525311B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH6505789 1978-06-14
CH650578 1978-06-14

Publications (2)

Publication Number Publication Date
AU4797779A true AU4797779A (en) 1979-12-20
AU525311B2 AU525311B2 (en) 1982-10-28

Family

ID=4310667

Family Applications (1)

Application Number Title Priority Date Filing Date
AU47977/79A Expired - Fee Related AU525311B2 (en) 1978-06-14 1979-06-12 Substituted aminoalkanoic acids

Country Status (17)

Country Link
EP (1) EP0006217B1 (en)
JP (1) JPS554375A (en)
AT (1) ATE797T1 (en)
AU (1) AU525311B2 (en)
BE (1) BE876934A (en)
DE (2) DE2962385D1 (en)
DK (1) DK245079A (en)
ES (1) ES481493A1 (en)
FR (1) FR2432502A1 (en)
GB (1) GB2024814A (en)
GR (1) GR65664B (en)
HU (1) HU180209B (en)
IL (1) IL57553A0 (en)
NZ (1) NZ190723A (en)
PL (1) PL216291A1 (en)
PT (1) PT69763A (en)
ZA (1) ZA792944B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4440941A (en) * 1980-12-22 1984-04-03 Usv Pharmaceutical Corporation Aroyl-aminoacids, amides and esters thereof
US4521607A (en) * 1981-02-27 1985-06-04 Takeda Chemical Industries, Ltd. Chromanyl glycines
US4686232A (en) * 1983-02-28 1987-08-11 Sumitomo Chemical Company, Limited Fungicidal aniline derivatives
JPS61185140A (en) * 1985-02-08 1986-08-18 ゼニヤ海洋サ−ビス株式会社 Apparatus for preventing generation of red tide
EP0221019B1 (en) * 1985-10-14 1994-01-05 Nippon Zoki Pharmaceutical Co. Ltd. Peptides
JPS62205095A (en) * 1986-03-04 1987-09-09 Toyo Jozo Co Ltd Novel physiologically active substance aldostatin and production thereof
JPH0226466U (en) * 1988-08-03 1990-02-21

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3697563A (en) * 1970-06-29 1972-10-10 Inst Chemioterapico Italiano S (3,4,5-trimethoxy-benzamido)-alkanoic acids for prophylaxis and treatment of cardiac disorders

Also Published As

Publication number Publication date
HU180209B (en) 1983-02-28
GB2024814A (en) 1980-01-16
GR65664B (en) 1980-10-16
ZA792944B (en) 1980-06-25
DE2962385D1 (en) 1982-05-06
ATE797T1 (en) 1982-04-15
BE876934A (en) 1979-12-12
EP0006217A1 (en) 1980-01-09
DE2923698A1 (en) 1980-01-03
PT69763A (en) 1979-07-01
IL57553A0 (en) 1979-10-31
ES481493A1 (en) 1980-03-01
EP0006217B1 (en) 1982-03-31
DK245079A (en) 1979-12-15
NZ190723A (en) 1981-12-15
AU525311B2 (en) 1982-10-28
PL216291A1 (en) 1980-03-24
FR2432502A1 (en) 1980-02-29
JPS554375A (en) 1980-01-12

Similar Documents

Publication Publication Date Title
DE2964709D1 (en) (dl)-16-phenoxy- and 16-substituted phenoxy-9-keto prostatrienoic acids and derivatives and processes for the production thereof and their pharmaceutical compositions
AU546379B2 (en) 4-pregnene-derivatives
FR2426694A1 (en) ADVANCED CEPHALOSPORINS, THEIR PREPARATION PROCESS AND THEIR THERAPEUTIC APPLICATION
NO179671C (en) Substituted cyclohexane derivatives, their use in the manufacture of drugs and drugs for the treatment of type II diabetes and other diseases
AU525311B2 (en) Substituted aminoalkanoic acids
DE3873870D1 (en) ANDROSTAN-17-CARBONIC ACID ESTER, METHOD FOR THE PRODUCTION THEREOF AND MEDICINAL PRODUCTS CONTAINING IT.
DK513080A (en) 6- (1-HYDROXYETHYL) -2- (2-AMINOETHYLTHIO) -1,1-DISUBSTITUTED 1-CARBADETHYAPEN-2-EM-3-CARBOXYLIC ACID AND PROCEDURE FOR PREPARING THEREOF
AU4452693A (en) Novel 2-saccharinylmethyl aryl carboxylates useful as proteolytic enzyme inhibitors and compositions and method ofuse thereof
DE69228541T2 (en) Quinic acid derivatives and process for the production of quinic acid derivatives
AU525423B2 (en) Substitutted amino acids
IE42425L (en) Aryloxy and arylthio-alkanoates having cholesterol-reducing¹properties.
DK166384C (en) METHOD OF ANALOGUE FOR THE PREPARATION OF (-) - 15-DEOXY PERGUALING AND PHARMACEUTICAL ACCEPTABLE ACID ADDITION SALTS AND INTERMEDIATE PRODUCTS
JPS5297934A (en) N#-arylsulfonyl-l-argininamides and their salts acceptable as medicine s
DK275784A (en) 6- (AMINOMETHYL) PENICILLANIC ACID-1,1-DIOXIDE ESTERS WHICH ARE HYDRO-LYSABLE UNDER PHYSIOLOGICAL CONDITIONS AND AMINO-PROTECTED 6- (AMINOMETHYL) PENICILLANIC ACID COMPOUNDS FOR USE WITHOUT USE
DK0551844T3 (en) Sulfur-containing bile acid derivatives
ES408236A1 (en) Method for producing pure 3,6-dioxo-4-hydroxy-tetrahydropyridazines
HUT55774A (en) Process for producing 13,14-dihydro-berbane derivatives and pharmaceutical compositions containing them